Role of Narrow-band Ultraviolet B Phototherapy with Topical Tacrolimus 0.03% for Treatment of Childhood Vitiligo

Abstract

ABSTRACT Vitiligo in children is a challenging disease to treat, as fewer safe options are available compared with the adult population. The combination of topical tacrolimus (0.03%) with narrowband ultraviolet B (NBUVB) phototherapy is a safer option and hence we decided to explore this in our study. The extent of repigmentation was assessed at baseline, 12 weeks, and 24 weeks by photographic documentation. We observed that out of 16 patients, 3 (18.75%) had <25% repigmentation, 7 (43.75%) had 25 to 75% repigmentation, and 6 (37.5%) achieved >75% repigmentation. Combined therapy with topical tacrolimus and NBUVB phototherapy is an excellent and safe modality in childhood vitiligo. How to cite this article Dixit A, Yadav P, Rathore PK, Goyal S. Role of Narrow-band Ultraviolet B Phototherapy with Topical Tacrolimus 0.03% for Treatment of Childhood Vitiligo. Int J Adv Integ Med Sci 2017;2(1):37-39.